Vol 68, No 4 (2017)
Review article
Published online: 2017-12-22

open access

Page views 1943
Article views/downloads 2335
Get Citation

Connect on Social Media

Connect on Social Media

Travel medicine for divers

Krzysztof Korzeniewski1, Jarosław Krzyżak2
Pubmed: 29297573
IMH 2017;68(4):215-228.

Abstract

Recreational diving is increasing in popularity globally, also among European travellers. Since a majority of popular diving sites are located in tropical or subtropical destinations commonly characterised by harsh climate and poor sanitation, travellers planning to engage in recreational diving are recommended to take certain health prevention measures to reduce travel-associated health risks. They need to be aware of the fact that diving can threaten their lives or even be fatal; however, if they are well prepared physically and mentally and follow all the recommended safety rules while underwater, diving is an unforgettable experience that cannot be compared to any other sports activity performed on land. Before going on a diving trip, it is important to make the necessary arrangements, bearing in mind they should not only concentrate on diving-related activities (the marine environment) but also on other aspects, e.g. contact with terrestrial flora and fauna. Therefore, the health prevention measures (a pre-travel consultation, vaccinations, antimalarial chemoprophylaxis, a properly prepared travel health kit and travel insurance) are to keep a traveller healthy during the entire travel and not just the moments of going underwater. The most important of the pre-travel arrangements include pre-travel medical evaluation, selecting and preparing medications for chronic conditions and assembling the first aid kit for personal use. Travellers are recommended to have a pre-travel consultation in medical facilities whose personnel have an appropriate level of knowledge and expertise on hyperbaric, tropical and travel medicine.

References

  1. Lynch JH, Bove AA, Lynch JH, et al. Diving medicine: a review of current evidence. J Am Board Fam Med. 2009; 22(4): 399–407.
  2. Marienau KJ, Arguin PM. Diving medicine. In: Keystone JS, Freedman DO, Kozarsky PE, Connor BA, Nothdurft HD. ed. Travel medicine. 3rd edition. Saunders, Philadelphia 2013: 373–378.
  3. Medical guidelines. Recreational Scuba Training Council. http://www.wrstc.com/downloads/10%20-%20Medical%20Guidelines.pdf (28 Sept 2017).
  4. Harrison D, Lloyd-Smith R, Khazei A, et al. Controversies in the medical clearance of recreational scuba divers: updates on asthma, diabetes mellitus, coronary artery disease, and patent foramen ovale. Curr Sports Med Rep. 2005; 4(5): 275–281.
  5. Dowse MS, Cridge C, Smerdon G. The use of drugs by UK recreational divers: prescribed and over-the-counter medications. Diving Hyperb Med. 2011; 41(1): 16–21.
  6. Leigh D. DAN discusses malaria and antimalarial drugs. Alert Diver Sept 2002. http://www.diversalertnetwork.org/medical/articles/article.asp?articleid=80 (28 Sept 2017).
  7. Denoble PJ, Caruso JL, Dear Gd, et al. Common causes of open-circuit recreational diving fatalities. Undersea Hyperb Med. 2008; 35(6): 393–406.
  8. British Thoracic Society Fitness to Dive Group, Subgroup of the British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines on respiratory aspects of fitness for diving. Thorax. 2003; 58(1): 3–13.
  9. Pollock NW, Uguccioni DM, Dear Gde L [Eds]. Diabetes and recreational diving: guidelines for the future. Proceedings of the UHMS/DAN 2005 June 19 Workshop. Durham, NC: Divers, Alert Network; 2005. http://www.diversalertnetwork.org/news/download/SummaryGuidelines.pdf (28 Sept 2017).
  10. Underwater physiology and diving disorders. In: U.S. Navy Diving Manual. Volume 1, Revision 6. http://www.supsalv.org/00c3_publications.asp (28 Sept 2017).
  11. Taylor L. Diving physics. In: Bove AA, Davis JC JC. ed. Diving Medicine. 4th Edition. Saunders, Philadelphia 2004: 11–35.
  12. Spira A. Diving and marine medicine review part I: diving physics and physiology. J Travel Med. 1999; 6(1): 32–44.
  13. Bove AA, Moon RE. Patent foramen ovale – is it important to divers? In: Alert Diver, Sept/Oct 2004. http://diversalertnetwork.org/medical/articles/article.asp? articleid=70 (28 Sept 2017).
  14. Vann RD, Lang MA [Eds]. Recreational Diving Fatalities. Proceedings of the Dives Alert Network 2010 April 8-10 Workshop. Durham, NC. http://d35gjurzz1vdcl. cloudfront.net/ftw-files/Fatalities_Proceedings.pdf (28 Sept 2017).
  15. World Health Organization. Immunization, Vaccines and Biologicals. http://www.who.int/topics/immunization/diseases/en/ (20 Sept 2017).
  16. Barnett ED. Yellow fever: epidemiology and prevention. Clin Infect Dis. 2007; 44(6): 850–856.
  17. Korzeniewski K. Medycyna podróży. PZWL, Warszawa 2016: 12–58.
  18. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009; 27 Suppl 2: B51–B63.
  19. Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj). Wkly Epidemiol Rec. 2009; 84(46): 477–480.
  20. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec. 2011; 86(47): 521–539.
  21. ProMED-mail. Poliomyelitis update: Global (Syria, Democratic Republic of the Congo). http://www.promedmail.org (22 Sept 2017).
  22. Polio eradication. AccessScience. .
  23. Cholera, 2015. Wkly Epidemiol Rec. 2016; 91: 433–440.
  24. ProMED-mail. Cholera, diarrhea and dysentery update: Asia (Yemen). http://www.promedmail.org (21 Sept 2017).
  25. ProMED-mail. Cholera, diarrhea and dysentery update: America (Haiti). http://www.promedmail.org (16 Aug 2017).
  26. Steinberg EB, Bishop R, Haber P, et al. Typhoid fever in travelers: who should be targeted for prevention? Clin Infect Dis. 2004; 39(2): 186–191.
  27. Guzman CA, Borsutzky S, Griot-Wenk M, et al. Vaccines against typhoid fever. Vaccine. 2006; 24(18): 3804–3811.
  28. Askling HH, Rombo L, Andersson Y, et al. Hepatitis A risk in travelers. J Travel Med. 2009; 16(4): 233–238.
  29. Grabenstein JD. Hepatitis A vaccine. ImmunoFacts 2006: 175–185.
  30. Keystone JS. Travel-related hepatitis B: risk factors and prevention using an accelerated vaccination schedule. Am J Med. 2005; 118 Suppl 10A: 63S–68S.
  31. Jack AD, Hall AJ, Maine N, et al. What level of hepatitis B antibody is protective? J Infect Dis. 1999; 179(2): 489–492.
  32. Nothdurft HD, Zuckerman J, Stoffel M, et al. Accelerated vaccination schedules provide protection against hepatitis A and B in last-minute travelers. J Travel Med. 2004; 11(4): 260–261.
  33. Gautret P, Wilder-Smith A. Vaccination against tetanus, diphtheria, pertussis and poliomyelitis in adult travellers. Travel Med Infect Dis. 2010; 8(3): 155–160.
  34. Rabies vaccines: WHO position paper. Wkly Epidemiol Rec. 2010; 85: 309–320.
  35. Halstead SB, Thomas SJ. Japanese encephalitis: new options for active immunization. Clin Infect Dis. 2010; 50(8): 1155–1164.
  36. Dubischar-Kastner K, Kaltenboeck A, Klingler A, et al. Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up. Vaccine. 2010; 28(39): 6463–6469.
  37. Brunette GW. Yellow Book 2018. Health Information for International Travel. Oxford University Press, New York 2017.